Anti-Müllerian hormone treatment enhances oocyte quality, embryonic development and live birth rate
Authors:
- 3 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 107 (3) , 813-822
Abstract
The anti-Müllerian hormone (AMH) produced by the granulosa cells of growing follicles is critical for folliculogenesis and is clinically used as a diagnostic and prognostic marker of female fertility. Previous studies report that AMH-pretreatment in mice creates a pool of quiescent follicles that are released following superovulation, resulting in an increased number of ovulated oocytes. However, the quality and developmental competency of oocytes derived from AMH-induced accumulated follicles as well as the effect of AMH treatment on live birth are not known. This study reports that AMH priming positively affects oocyte maturation and early embryonic development culminating in higher number of live births. Our results show that AMH treatment results in good-quality oocytes with greater developmental competence that enhances embryonic development resulting in blastocysts with higher gene expression. The transcriptomic analysis of oocytes from AMH-primed mice compared with those of control mice reveal that AMH upregulates a large number of genes and pathways associated with oocyte quality and embryonic development. Mitochondrial function is the most affected pathway by AMH priming, which is supported by more abundant active mitochondria, mitochondrial DNA content and adenosine triphosphate levels in oocytes and embryos isolated from AMH-primed animals compared with control animals. These studies for the first time provide an insight into the overall impact of AMH on female fertility and highlight the critical knowledge necessary to develop AMH as a therapeutic option to improve female fertility.Keywords
Funding Information
- MSU AgBioResearch (R01GM131398)
- USDA-Hatch (MICL02383)
- NIH (R01HD086062)
This publication has 65 references indexed in Scilit:
- Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cellsFertility and Sterility, 2013
- Gene Expression Profiling of Human Oocytes Developed and MaturedIn VivoorIn VitroBioMed Research International, 2013
- SOX2 Modulates Reprogramming of Gene Expression in Two-Cell Mouse Embryos1Biology of Reproduction, 2011
- Granulosa Cell-Specific Androgen Receptors Are Critical Regulators of Ovarian Development and FunctionMolecular Endocrinology, 2010
- Bidirectional communication between oocytes and follicle cells: ensuring oocyte developmental competenceCanadian Journal of Physiology and Pharmacology, 2010
- Maternal control of early mouse developmentDevelopment, 2010
- Mitochondrial functions on oocytes and preimplantation embryosJournal of Zhejiang University-SCIENCE B, 2009
- Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian functionFertility and Sterility, 2009
- Human ribosomal protein S13 regulates expression of its own gene at the splicing step by a feedback mechanismNucleic Acids Research, 2007
- Nanog and transcriptional networks in embryonic stem cell pluripotencyCell Research, 2007